abstract |
Compounds of formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 23 , R 24 , L, A and B are as defined in claim 1, or pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (I) possess utility as cytochrome P450 monooxygenase 11A1 (CYP11A1) inhibitors. The compounds are useful as medicaments in the treatment of steroidreceptor, particularly androgen receptor, dependent diseases and conditions, such as prostate cancer. |